FirstEnergy Corp. vs Revolution Medicines Inc. Common Stock — how do they compare? FirstEnergy Corp. trades at $45 (market cap $25.95B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is the larger of the two by market cap, and FirstEnergy Corp. pays a 4.15% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FirstEnergy Corp. for 71 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FE | RVMD | |
|---|---|---|
Market Cap | $25.95B | $40.32B |
Volume | 5,643,833 | 4,855,734 |
Sector | Utilities | Health |
52-Week High | $51.91 | $221.15 |
52-Week Low | $43.04 | $47.50 |
Typical Hold Time | 71 Days | 0 Days |
Enterprise Value | $54.87B | $37.02B |
Dividend Yield | 4.15% | — |
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $44.85, up 0.61% with a bearish technical signal despite recent earnings beats. The utility shows steady revenue growth to $15.09B in 2025 with a 6.86% net margin, though cash flow trends negative due to heavy infrastructure investments. Analysts maintain a Moderate Buy consensus with a $52.80 price target, representing 18% upside potential from current levels.
The stock offers income potential with consistent dividends but faces execution risks from its $36B Energize365 capital plan. While valuation appears reasonable at 24x P/E, investors should monitor debt levels and regulatory approvals for rate base expansion. Technical resistance at $45-46 may limit near-term gains despite fundamental strength.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →